78645559
Jun 7, 2005
BIOPHARMACEUTICAL AND BIOTECHNOLOGY REAGENTS, NAMELY, HYBRIDOMA-GENERATED ANTIBODIES AND MAMMALIAN ANTIBODIES AND RECOMBINANT FRAGMENTS THEREOF FOR MEDICAL DIAGNOSTIC USE IN THE TREATMENT OF CANCER; BIOPHARMACEUTICAL PREPARATIONS FOR USE IN IMMUNOTHERAPY AND DIAGNOSTICS, NAMELY, MONOCLONAL ANTIBODIES AND BINDING FRAGMENTS THEREOF AND IMMUNOCONJUGATES, PARTICULARLY FOR TREATMENT OF CANCER; BIOTECHNOLOGY PRODUCTS FOR USE IN IMMUNOTHERAPY AND DIAGNOSTICS, NAMELY, MONOCLONAL ANTIBODIES AND BINDING FRAGMENTS THEREOF AND IMMUNOCONJUGATES, PARTICULARLY FOR THE DETECTION AND TREATMENT OF CANCER
PharmaceuticalsProduct research and development in connection with the biopharmaceutical and biotechnology industries
Computer and Scientific